Tibet Aim Pharm Inc (002826) — Net Asset Quality Index
Tibet Aim Pharm Inc (002826) has a Net Asset Quality Index of 76.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.10 Billion minus total liabilities of CN¥265.27 Million yields net assets of CN¥838.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Tibet Aim Pharm Inc (002826) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tibet Aim Pharm Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Tibet Aim Pharm Inc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 76.0%, representing net assets of CN¥838.02 Million against total assets of CN¥1.10 Billion CNY. See 002826 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tibet Aim Pharm Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Tibet Aim Pharm Inc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 002826 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | CN¥816.02 Million | CN¥1.02 Billion | CN¥201.65 Million | ▼ -0.3 pp |
| 2024 | 80.5% | CN¥745.58 Million | CN¥926.47 Million | CN¥180.89 Million | ▼ -0.4 pp |
| 2023 | 80.8% | CN¥750.06 Million | CN¥927.74 Million | CN¥177.68 Million | ▲ +7.2 pp |
| 2022 | 73.7% | CN¥750.00 Million | CN¥1.02 Billion | CN¥268.21 Million | ▼ -13.7 pp |
| 2021 | 87.3% | CN¥720.11 Million | CN¥824.47 Million | CN¥104.36 Million | ▲ +11.7 pp |
| 2020 | 75.7% | CN¥687.15 Million | CN¥908.09 Million | CN¥220.94 Million | ▼ -2.4 pp |
| 2019 | 78.1% | CN¥652.17 Million | CN¥835.41 Million | CN¥183.24 Million | ▼ -3.5 pp |
| 2018 | 81.6% | CN¥618.40 Million | CN¥757.93 Million | CN¥139.53 Million | ▼ -0.9 pp |
| 2017 | 82.4% | CN¥604.53 Million | CN¥733.29 Million | CN¥128.76 Million | ▼ -3.5 pp |
| 2016 | 85.9% | CN¥555.44 Million | CN¥646.36 Million | CN¥90.93 Million | ▲ +23.5 pp |
| 2015 | 62.4% | CN¥248.25 Million | CN¥397.70 Million | CN¥149.44 Million | ▼ -4.3 pp |
| 2014 | 66.7% | CN¥179.12 Million | CN¥268.42 Million | CN¥89.30 Million | ▲ +19.9 pp |
| 2013 | 46.8% | CN¥71.66 Million | CN¥153.10 Million | CN¥81.43 Million | — |